# Drug-Drug Interaction Study of AG120 in Healthy Subjects

> **NCT02831972** · PHASE1 · COMPLETED · sponsor: **Agios Pharmaceuticals, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AG120
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT02831972
- **Lead sponsor:** Agios Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02831972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02831972, "Drug-Drug Interaction Study of AG120 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02831972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
